Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05341804
Other study ID # KMUHIRB-F(I)-20210071
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 10, 2022
Est. completion date September 15, 2023

Study information

Verified date April 2024
Source Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After developing and pilot testing the training program, including the CogBals software, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants and then randomly allocated to the cognitive and balance dual task training group (COG&BAL), the balance training group (BAL), and the treatment as usual group. The first two training groups (COG&BAL, BAL) receive training for 60 minutes in a group format, 2 times weekly, for 12 weeks. All participants will be assessed at baseline and posttest. The primary outcome is balance function and secondary outcomes are cognitive functions and the muscular endurance of lower extremities.


Description:

Background: Individuals with schizophrenia often experience premature aging and accelerated aging, which increases the challenge of care and recovery. Improvement on balance and implementation of prevention from and deceleration of the disability process is of the critical issues in psychiatric rehabilitation. Unfortunately, evidence- based effective programs are limited. Recently, a novel balance training program through cognitive and balance dual task training has shown better outcomes in the elderly and other clinical populations. Yet, the dual task balance training has not been examined for schizophrenia. This dual task balance training with the Internet of Thing techniques is a novel and important program for middle-aged and older individuals with schizophrenia. Further study is needed to develop the training program and to examine the effectiveness. Purposes: (1) To develop a cognitive and balance dual task training program involving the Internet of Thing technique software - Cognitive and Balance training Simultaneously software (CogBals software) (1st year); (2) to pilot the feasibility of the balance training program for the middle-aged and older individuals with schizophrenia and revise it (1st year); and (3) to examine the effects of the balance training program on balance, cognitive functions, and the muscular endurance of lower extremities (2nd to 3rd year). Methods: For the effectiveness analysis phase, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants and then randomly allocated to the cognitive and balance dual task training group (COG&BAL), the balance training group (BAL), and the treatment as usual group. The first two training groups (COG&BAL, BAL) receive training for 60 minutes in a group format, 2 times weekly, for 12 weeks. All participants will be assessed at baseline and posttest. The primary outcome is balance function and secondary outcomes are cognitive functions and the muscular endurance of lower extremities. Contribution: The study uses cognitive and balance dual task training and expect better outcomes on balance improvement. The program can serve as an evidence- based program to prevent and to decelerate the disability process from people with mental illness. The CogBals software developed by researchers and training in a group format is good to promote in the clinical setting with less manpower.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date September 15, 2023
Est. primary completion date September 15, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: 1. diagnosis of schizophrenia or schizoaffective disorder for more than 1 year by psychiatrist according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) 2. age 40-75 years old 3. have stable psychiatric symptoms currently (main psychotropic medications have not been adjusted for two months 4. being able to ambulate independently for more than 10 meters, without a walking device 5. not have significant cognitive impairment (Montreal Cognitive Assessment Taiwan Version, MoCA?20) 6. can follow study protocol and sign the informed consent form Exclusion Criteria: 1. currently in the psychiatric acute award 2. currently alcohol or drug use disorder 3. Pregnancy, head trauma and other neuromusculoskeletal injuries affect training safety and compliance 4. intellectual disability 5. Unconsciousness or confusion 6. According to the subject's self-report, those with the following medical history, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, poor blood sugar control (i.e., renal dialysis treatment, diabetic neuropathy or retinopathy), no well-controlled hyperemia: systolic blood pressure> 160 mmHg or diastolic blood pressure> 110 mmHg 7. Currently participating in other interventional study

Study Design


Intervention

Behavioral:
cognitive and balance dual task training
a cognitive and balance dual task training program involving the Internet of Thing technique software - Cognitive and Balance training Simultaneously software
balance training
Includes static balance, dynamic balance and strength training

Locations

Country Name City State
Taiwan Kaohsiung Medical University Kaohsiung

Sponsors (3)

Lead Sponsor Collaborator
Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Medical University, Ministry of Science and Technology, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mini-Balance Evaluation System Test score from 0-28; higher score is better Change from baseline at 12 weeks
Primary Timed up and go test under single and dual tasks dual tasks include carrying a cup of water and calculation Change from baseline at 12 weeks
Primary Single leg stance test under single and dual tasks dual tasks include carrying a cup of water and calculation Change from baseline at 12 weeks
Primary Chinese version of Activities-specific Balance Confidence Scale score from 0-100; higher score is better Change from baseline at 12 weeks
Primary 6 meter walk test Change from baseline at 12 weeks
Secondary Symbol Coding The participant writes as many answers as possible within 90 seconds. Change from baseline at 12 weeks
Secondary Digit Span score from 0-33; higher score is better Change from baseline at 12 weeks
Secondary Spatial Span score from 0-32; higher score is better Change from baseline at 12 weeks
Secondary The Stroop Color and Word Test The participant reads color words or names ink colors from different pages as quickly as possible within 45 seconds. Change from baseline at 12 weeks
Secondary Color Trials Test Color Trials 1 and Color Trials 2 Change from baseline at 12 weeks
Secondary 30-second sit to stand test The participant completes as many full stands as possible within 30 seconds. Change from baseline at 12 weeks
Secondary Bilateral standing heel-rise test The participant performs the maximum number of plantar flexions possible, until the point of voluntary fatigue, as fast as possible. Change from baseline at 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A